john constantine, you are probably right regarding Pattersons. However, just reading Dirks blog, I had noticed that Gene Genie has responded to a very negative poster on DNA directed shRNA production methods. He/she has a different perspective on BLT's "white knight", so I thought I would post it hear for hc members benefit.
Gene Genie said... I dont know why it is clear shRNA will never succeed ? Nature has developed 3 ways to deal with disease , medical science has discovered and developed these in reverse order . Small molecules almost all are derived from plant chemicals eg Aspirin , taxol , these chremicals or hard wired immunity is the reason rice has twice as many genes as humans. Next came antibodies , an adaptive immunity , is it no coincidence Benitecs white Knight investor is the same person who brought Bristol Myers Squibb to Inclone when that company had a 20 m market cap and monoclonal antibodies were just a pipe dream ( Inclone was taken over by J&J for 7.3 billion), shrna was the first of natures ways to treat disease and for half the time of life on earth was the only immune process as life was unicellular , it was the last to be discovered but quite possibly will be the most effective of the three approaches its just at the earliest stage of development. It has the potential to deal with everything from antibiotic resistance to hereditary genetic disorders. Look at the thousands of successes in the use of this approach on the research side, I think only time will tell but I would not bet against mother nature.
May 9, 2011 5:46 PM
BLT Price at posting:
60.0¢ Sentiment: Hold Disclosure: Held
